{
    "DATE": "11-MAR-1987 10:19:26.57",
    "TOPICS": [
        "earn"
    ],
    "PLACES": [
        "denmark"
    ],
    "NEWID": "3630",
    "TEXT": {
        "TITLE": "NOVO INDUSTRI EARNINGS FALL DESPITE INCREASED SALES",
        "DATELINE": "    COPENHAGEN, March 11 - ",
        "BODY": "Danish-based insulin and enzymes\nproducer Novo Industri A/S (NVO.CO) said pre-tax earnings fell\nalmost 10 pct in 1986 though sales rose by two pct.\n    The pre-tax figure fell to 788 mln crowns from 872 mln in\n1985, on sales increased from 4.1 billion to 4.2 billion,\ngiving net earnings of 521 mln crowns against 604 mln in 1985.\n    Earnings per 20-crown share went from 23.79 crowns to 20.45\ncrowns but the company proposed an unchanged 20 pct dividend.\n    \"Foreign exchange fluctuations in 1986 were a very\nsignificant factor behind developments in the result before and\nafter tax,\" Novo said in a statement.\n    \"Not only the U.S. Dollar but also other currencies\nessential to Novo fell in 1986 in relation to the Danish crown,\"\nthe statement added.\n    In November 1986, Novo purchased 75 pct of shares in A/S\nFerrosan, which heads a group specialising in research and\ndevelopment of CNS (central nervous treatment) treatments and\nthe sale of pharmaceuticals and vitamins in Scandinavia.\n    The 357 mln crowns paid in goodwill \"had a very limited\neffect on the 1986 result,\" the Novo statement said.\n Reuter\n\u0003"
    },
    "ORGS": [
        "ec"
    ],
    "PEOPLE": [
        "sumita"
    ],
    "EXCHENGES": [
        "cbt"
    ]
}